1596. Ceftolozane/tazobactam (Zerbaxa) for the Treatment of Pseudomonas aeruginosa (PSA) Bacteremia: A Systematic Literature Review (SLR)

BACKGROUND: Bacteremia is a significant cause of morbidity and mortality. Several studies have shown this burden to increase among patients with multidrug resistant (MDR) PSA, and in those treated with inappropriate empiric therapy. Ceftolozane/tazobactam (C/T) is a combination of a novel antipseudo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Dillon, Ryan J, Khankhel, Zarmina S, De Anda, Carisa, Bruno, Christopher, Puzniak, Laura A
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Poster Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778241/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1776
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki